Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

222 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Benefits from immunization during the vaccines for children program era - United States, 1994-2013.
Whitney CG, Zhou F, Singleton J, Schuchat A; Centers for Disease Control and Prevention (CDC). Whitney CG, et al. Among authors: schuchat a. MMWR Morb Mortal Wkly Rep. 2014 Apr 25;63(16):352-5. MMWR Morb Mortal Wkly Rep. 2014. PMID: 24759657 Free PMC article.
VFC was designed to ensure that eligible children do not contract vaccine-preventable diseases because of inability to pay for vaccine and was created in response to a measles resurgence in the United States that resulted in approximately 55,000 cases reported during 1989- …
VFC was designed to ensure that eligible children do not contract vaccine-preventable diseases because of inability to pay for vaccine and w …
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014.
Bialek SR, Allen D, Alvarado-Ramy F, Arthur R, Balajee A, Bell D, Best S, Blackmore C, Breakwell L, Cannons A, Brown C, Cetron M, Chea N, Chommanard C, Cohen N, Conover C, Crespo A, Creviston J, Curns AT, Dahl R, Dearth S, DeMaria A, Echols F, Erdman DD, Feikin D, Frias M, Gerber SI, Gulati R, Hale C, Haynes LM, Heberlein-Larson L, Holton K, Ijaz K, Kapoor M, Kohl K, Kuhar DT, Kumar AM, Kundich M, Lippold S, Liu L, Lovchik JC, Madoff L, Martell S, Matthews S, Moore J, Murray LR, Onofrey S, Pallansch MA, Pesik N, Pham H, Pillai S, Pontones P, Pringle K, Pritchard S, Rasmussen S, Richards S, Sandoval M, Schneider E, Schuchat A, Sheedy K, Sherin K, Swerdlow DL, Tappero JW, Vernon MO, Watkins S, Watson J; Centers for Disease Control and Prevention (CDC). Bialek SR, et al. Among authors: schuchat a. MMWR Morb Mortal Wkly Rep. 2014 May 16;63(19):431-6. MMWR Morb Mortal Wkly Rep. 2014. PMID: 24827411 Free PMC article.
The first case of MERS in the United States, identified in a traveler recently returned from Saudi Arabia, was reported to CDC by the Indiana State Department of Health on May 1, 2014, and confirmed by CDC on May 2. A second imported case of MERS in the United State …
The first case of MERS in the United States, identified in a traveler recently returned from Saudi Arabia, was reported to CDC by the …
The state of immunization 2013: we are the world.
Schuchat A. Schuchat A. S D Med. 2013;Spec no:27-32. S D Med. 2013. PMID: 23444588 Review.
However, importations of measles virus from other countries, resurgences of pertussis and mumps, and the 2009 pandemic of influenza A H1N1 are reminders that Americans remain vulnerable to vaccine-preventable diseases and that sustained support for public health and clinic …
However, importations of measles virus from other countries, resurgences of pertussis and mumps, and the 2009 pandemic of influenza A
Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.
Pilishvili T, Zell ER, Farley MM, Schaffner W, Lynfield R, Nyquist AC, Vazquez M, Bennett NM, Reingold A, Thomas A, Jackson D, Schuchat A, Whitney CG. Pilishvili T, et al. Among authors: schuchat a. Pediatrics. 2010 Jul;126(1):e9-17. doi: 10.1542/peds.2009-2150. Epub 2010 Jun 14. Pediatrics. 2010. PMID: 20547641
OBJECTIVE: We conducted a case-control study to evaluate risk factors for invasive pneumococcal disease (IPD) among children who were aged 3 to 59 months in the era of pneumococcal conjugate vaccine (PCV7). ...We matched a median of 3 control subjects to each case p …
OBJECTIVE: We conducted a case-control study to evaluate risk factors for invasive pneumococcal disease (IPD) among children who were …
Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.
Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Schrag S, et al. Among authors: schuchat a. MMWR Recomm Rep. 2002 Aug 16;51(RR-11):1-22. MMWR Recomm Rep. 2002. PMID: 12211284
Group B streptococcus (GBS) remains a leading cause of serious neonatal infection despite great progress in perinatal GBS disease prevention in the 1990s. ...Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45[RR-7]:1-24) …
Group B streptococcus (GBS) remains a leading cause of serious neonatal infection despite great progress in perinatal GBS disease pre …
Should college students be vaccinated against meningococcal disease? A cost-benefit analysis.
Jackson LA, Schuchat A, Gorsky RD, Wenger JD. Jackson LA, et al. Among authors: schuchat a. Am J Public Health. 1995 Jun;85(6):843-5. doi: 10.2105/ajph.85.6.843. Am J Public Health. 1995. PMID: 7762722 Free PMC article.
Outbreaks and sporadic cases of meningococcal disease among college students have prompted consideration of a policy of routine vaccination for this group. ...More cost-effective prevention strategies might be yielded by further studies to identify students at substantial …
Outbreaks and sporadic cases of meningococcal disease among college students have prompted consideration of a policy of routine vacci …
Serogroup C meningococcal outbreaks in the United States. An emerging threat.
Jackson LA, Schuchat A, Reeves MW, Wenger JD. Jackson LA, et al. Among authors: schuchat a. JAMA. 1995 Feb 1;273(5):383-9. JAMA. 1995. PMID: 7823383
DEFINITION OF AN OUTBREAK: Three or more cases of serogroup C meningococcal disease within a 3-month period, either among members of a community or persons attending a single school or other institution, for which those cases represented an attack rate of at …
DEFINITION OF AN OUTBREAK: Three or more cases of serogroup C meningococcal disease within a 3-month period, either among members of …
Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.
Lingappa JR, Rosenstein N, Zell ER, Shutt KA, Schuchat A, Perkins BA; Active Bacterial Core surveillance (ABCs) team. Lingappa JR, et al. Among authors: schuchat a. Vaccine. 2001 Aug 14;19(31):4566-75. doi: 10.1016/s0264-410x(01)00209-2. Vaccine. 2001. PMID: 11483285
BACKGROUND: Neisseria meningitidis is a leading cause of bacterial meningitis in US; new capsular type-specific conjugate vaccines offer an opportunity for improved control of meningococcal disease. ...Although we examined possible conjugate vaccine formulations including …
BACKGROUND: Neisseria meningitidis is a leading cause of bacterial meningitis in US; new capsular type-specific conjugate vaccines of …
Zika Virus 6 Months Later.
Frieden TR, Schuchat A, Petersen LR. Frieden TR, et al. Among authors: schuchat a. JAMA. 2016 Oct 11;316(14):1443-1444. doi: 10.1001/jama.2016.11941. JAMA. 2016. PMID: 27532277 No abstract available.
New Data on Opioid Use and Prescribing in the United States.
Schuchat A, Houry D, Guy GP Jr. Schuchat A, et al. JAMA. 2017 Aug 1;318(5):425-426. doi: 10.1001/jama.2017.8913. JAMA. 2017. PMID: 28687823 Free PMC article. No abstract available.
222 results
Jump to page
Feedback